These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16361959)

  • 1. Hormone replacement therapy, brain volumes and white matter in postmenopausal women aged 60-64 years.
    Low LF; Anstey KJ; Maller J; Kumar R; Wen W; Lux O; Salonikas C; Naidoo D; Sachdev P
    Neuroreport; 2006 Jan; 17(1):101-4. PubMed ID: 16361959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in brain volumes among males and female hormone-therapy users and nonusers.
    Greenberg DL; Payne ME; MacFall JR; Provenzale JM; Steffens DC; Krishnan RR
    Psychiatry Res; 2006 Oct; 147(2-3):127-34. PubMed ID: 16935478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study.
    Schmidt R; Fazekas F; Reinhart B; Kapeller P; Fazekas G; Offenbacher H; Eber B; Schumacher M; Freidl W
    J Am Geriatr Soc; 1996 Nov; 44(11):1307-13. PubMed ID: 8909345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy and brain structure in postmenopausal women.
    Molano JR
    Neurology; 2016 Aug; 87(9):e100-2. PubMed ID: 27572433
    [No Abstract]   [Full Text] [Related]  

  • 5. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect.
    Lord C; Buss C; Lupien SJ; Pruessner JC
    Neurobiol Aging; 2008 Jan; 29(1):95-101. PubMed ID: 17030472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estrogen therapy on age-related differences in gray matter concentration.
    Robertson D; Craig M; van Amelsvoort T; Daly E; Moore C; Simmons A; Whitehead M; Morris R; Murphy D
    Climacteric; 2009 Aug; 12(4):301-9. PubMed ID: 19415541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain volumes in late life: gender, hormone treatment, and estrogen receptor variants.
    Ryan J; Artero S; Carrière I; Scali J; Maller JJ; Meslin C; Ritchie K; Scarabin PY; Ancelin ML
    Neurobiol Aging; 2014 Mar; 35(3):645-54. PubMed ID: 24269019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study.
    Boccardi M; Ghidoni R; Govoni S; Testa C; Benussi L; Bonetti M; Binetti G; Frisoni GB
    Menopause; 2006; 13(4):584-91. PubMed ID: 16837880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary evidence that estrogen protects against age-related hippocampal atrophy.
    Eberling JL; Wu C; Haan MN; Mungas D; Buonocore M; Jagust WJ
    Neurobiol Aging; 2003 Sep; 24(5):725-32. PubMed ID: 12885580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
    Maffei S; Del Ry S; Prontera C; Clerico A
    Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study.
    Luoto R; Manolio T; Meilahn E; Bhadelia R; Furberg C; Cooper L; Kraut M
    J Am Geriatr Soc; 2000 May; 48(5):467-72. PubMed ID: 10811537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging.
    Smith YR; Love T; Persad CC; Tkaczyk A; Nichols TE; Zubieta JK
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4476-81. PubMed ID: 16912129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct cognitive effects of estrogen and progesterone in menopausal women.
    Berent-Spillson A; Briceno E; Pinsky A; Simmen A; Persad CC; Zubieta JK; Smith YR
    Psychoneuroendocrinology; 2015 Sep; 59():25-36. PubMed ID: 26010861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women: evidence for a limited window of opportunity.
    Erickson KI; Voss MW; Prakash RS; Chaddock L; Kramer AF
    Neuropsychology; 2010 Jan; 24(1):68-76. PubMed ID: 20063947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection from current literature: hormone replacement therapy in postmenopausal women.
    Robbins A; Trilling JS
    Fam Pract; 1995 Mar; 12(1):115-21. PubMed ID: 7665031
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary evidence that long-term estrogen use reduces white matter loss in aging.
    Ha DM; Xu J; Janowsky JS
    Neurobiol Aging; 2007 Dec; 28(12):1936-40. PubMed ID: 17030475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner.
    Hu L; Yue Y; Zuo PP; Jin ZY; Feng F; You H; Li ML; Ge QS
    Chin Med Sci J; 2006 Dec; 21(4):214-8. PubMed ID: 17249194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities, hot flushes and estrogen--are they related?
    Pines A
    Climacteric; 2015; 18(6):775-6. PubMed ID: 26329986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHEA replacement for postmenopausal women: have we been looking in the right direction?
    Genazzani AR; Pluchino N
    Climacteric; 2015 Oct; 18(5):669-71. PubMed ID: 25961114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators.
    Robinson JC; Folsom AR; Nabulsi AA; Watson R; Brancati FL; Cai J
    Diabetes Care; 1996 May; 19(5):480-5. PubMed ID: 8732713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.